Piperlongumine slowed knee osteoarthritis progression in rats
In experiments, rats with induced knee osteoarthritis had less damage to the joint’s cushioning tissues and less inflammation when given piperlongumine.
Our read
Interventions- Studied:
- Experiments in rats with induced knee osteoarthritis
- What changed:
- Piperlongumine alleviated meniscus and cartilage degeneration and suppressed synovitis in rats with knee osteoarthritis
- The catch:
- The abstract does not report animal numbers, dose, or treatment duration
- In the record:
- The 4th paper on piperlongumine with results in people; 22 on record in all.
- Why it’s aging research:
- It studies an intervention with evidence of extending healthy life.
Editor of record: Boris Djordjevic · AgingResearch.News
In an animal experiment, rats with induced knee osteoarthritis, a disease that damages joints, received piperlongumine. The researchers also tested the compound in rat cells made senescent with hydrogen peroxide and in cells grown from people with osteoarthritis. Senescence is a state in which cells stop dividing.
The researchers found increased signs of senescence in the rats’ cartilage and meniscus, the knee’s cushioning pad. In rat cells grown in the lab, piperlongumine selectively killed senescent cells without harming normal cells. In cells from people with osteoarthritis, it reduced senescent cell numbers and increased production of glycosaminoglycans, molecules found in cartilage. In rats with osteoarthritis, it reduced meniscus and cartilage damage, lowered senescence markers and reduced inflammation of the joint lining.
Why it matters
For aging research, the work addresses whether clearing senescent cells from joint tissues could help slow osteoarthritis.
Caveats
The evidence came from rats and cells grown in the lab, not treatment studies in people. The abstract does not report animal numbers, dose or treatment duration.
The paper
Institute of Science Tokyo
Biochemical and Biophysical Research Communications, Jun 19, 2026, Open access
Comments
Be the first to comment.